Commonwealth Biotechnologies, Inc. Receives Marketplace Rule 4310(c)(3) and Going Concern Notices
RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market:CBTE), a life sciences contract research organization and biotechnology company, announced that a Going Concern qualification has been added by its independent auditor's report for fiscal year 2008 which was filed with the Company's Annual Report and Form 10-K on March 31, 2009.